Prof. Dinnyes has been working on embryology, cloning and stem cell biology since 1985. He was a Fulbright Scholar in the National Zoo, Washington D.C., and worked at leading institutions in US, Belgium, Japan, New Zealand, China, UK, The Netherlands. In 2000 joined the „Dolly cloning team” team in Roslin Institute, UK as team leader. In Hungary he produced the first cloned mice and rabbit. He is full professor at the Hungarian Agricultural and Life Sciences University. Since 2005 as founder and CEO, he is leading BioTalentum Ltd focusing on human pluripotent stem cell research for biomedical, toxicology and pharma purposes and regenerative medicine. He was a Wellcome Trust International Senior Research Fellow and obtained more than 40 EU FP6/7/Horizon2020/Horizon Europe grants to Hungary, scientifically coordinating 15 of them. He has received the “Denis Gabor Innovation Award”, member of the Academia Europaea and Honorary Professor of Sichuan University, China. His current work includes hiPSC-based rare diseases modelling and ASO therapy projects, in vitro disease modelling and toxicology using 2D, 3D and organ-on-a-chip new approach methodologies (NAMs). In 2024 he has started an IPCEI Med4Cure project for clinical translation of hiPSC-based Type-1 diabetes regenerative therapy and xeno-heart transplantation to cure cardiac failure.